Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa

AIDS

Volumn 27, Issue 6, 2013, Pages 1001-1009

  McCoy, Sandra I ^a   Zheng, Wenjing ^a   Montgomery, Elizabeth T ^b   Blanchard, Kelly ^c   Van Der Straten, Ariane ^b,d   De Bruyn, Guy ^e   Padian, Nancy S ^a,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b RTI INTERNATIONAL   (United States)

^c IBIS REPRODUCTIVE HEALTH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^f U S DEPARTMENT OF STATE   (United States)

Author keywords

Depot medroxyprogesterone acetate; HIV infection; Hormonal contraception; Oral contraceptives; Prevention; Women

Indexed keywords

GESTAGEN; LUBRICATING AGENT; MEDROXYPROGESTERONE ACETATE; ORAL CONTRACEPTIVE AGENT;

ADULT; AFRICA SOUTH OF THE SAHARA; AGE DISTRIBUTION; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GEL; HORMONAL CONTRACEPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; PHASE 2 CLINICAL TRIAL; PREGNANCY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; REPRODUCTIVE HEALTH; SECONDARY ANALYSIS; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASE; ZIMBABWE;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AFRICA SOUTH OF THE SAHARA; CONTRACEPTION; CONTRACEPTIVE AGENTS; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; INTERVIEWS AS TOPIC; MIDDLE AGED; RISK ASSESSMENT; SEXUAL BEHAVIOR; YOUNG ADULT;

EID: 84876419810     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32835da401     Document Type: Article

References (37)

1. United Nations Department of Economic and Social Affairs. World contraceptive use 2011. New York: United Nations; 2011.
2. UNAIDS. Report on the global AIDS epidemic. Geneva, Switzerland: UNAIDS; 2010. 3. Pettifor AE, Rees HV, Kleinschmidt I, Steffenson AE, MacPhail C, Hlongwa-Madikizela L, et al. Young people's sexual health in South Africa: HIV prevalence and sexual behaviors from a nationally representative household survey. AIDS 2005; 19:1525-1534.
3. Boonstra HD. Learning from adolescents to prevent HIV and unintended pregnancy. New York: Guttmacher Institute; 2007.
4. Morrison CS, TurnerAN, Jones LB. Highly effective contraception and acquisition of HIV and other sexually transmitted infections. Best Pract Res Clin Obstet Gynaecol 2009; 23:263-284.
5. Morrison CS, Nanda K. Hormonal contraception and HIV: an unanswered question. Lancet Infect Dis 2012; 12:2-3.
6. Hel Z, Stringer E, Mestecky J. Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection. Endocrine Rev 2010; 31:79-97.
7. Trunova N, Tsai L, Tung S, Schneider E, Harouse J, Gettie A, et al. Progestin-based contraceptive suppresses cellular immune responses in SHIV-infected rhesus macaques. Virology 2006; 352:169-177.
8. Marx PA, Spira AI, Gettie A, Dailey PJ, Veazey RS, Lackner AA, et al. Progesterone implants enhance SIV vaginal transmission and early virus load. Nature Med 1996; 2:1084-1089.
9. Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E, et al. Use of hormonal contraceptives and risk of HIV-1 transmission: A prospective cohort study. Lancet Infect Dis 2012; 12:19-26.
10. Morrison CS, Chen PL, Kwok C, Richardson BA, Chipato T, Mugerwa R, et al. Hormonal contraception and HIV acquisition: reanalysis using marginal structural modeling. AIDS 2010; 24:1778-1781.
11. Wand H, Ramjee G. The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections. AIDS 2012; 26:375-380.
12. Baeten JM, Benki S, Chohan V, Lavreys L, McClelland RS, Mandaliya K, et al. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women. AIDS 2007; 21:1771-1777.
13. Watson-Jones D, Baisley K, Weiss HA, Tanton C, Changalucha J, Everett D, et al. Risk factors for HIV incidence in women participating in an HSV suppressive treatment trial in Tanzania. AIDS 2009; 23:415-422.
14. Plummer FA, Simonsen JN, Cameron DW, Ndinya-Achola JO, Kreiss JK, Gakinya MN, et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991; 163:233-239.
15. Morrison CS, Skoler-Karpoff S, Kwok C, Chen PL, van de Wijgert J, Gehret-Plagianos M, et al. Hormonal contraception and the risk of HIV acquisition among women in South Africa. AIDS 2012; 26:497-504.
16. Myer L, Denny L, Wright TC, Kuhn L. Prospective study of hormonal contraception and women's risk of HIV infection in South Africa. Int J Epidemiol 2007; 36:166-174.
17. Radloff S. USAID communication to the field (October 7, 2011): USAID updated response to publication of findings on hormonal contraception and HIV acquisition in uninfected women and HIV transmission from infected women to men. United States Agency for International Development (USAID); 2011.
18. World Health Organization. Statement on the Heffron et al. study on the safety of using hormonal contraceptives for women at risk of HIV infection. Geneva, Switzerland: Department of Reproductive Health and Research, World Health Organization; 2011.
19. World Health Organization. Medical eligibility criteria for contraceptive use. 4th ed. Geneva, Switzerland: Department of Reproductive Health and Research, World Health Organization; 2010.
20. Department of Reproductive Health and Research. Hormonal contraception and HIV. Technical statement. Geneva, Switzerland: World Health Organization; 2012.
21. Padian NS, van der Straten A, Ramjee G, Chipato T, de Bruyn G, Blanchard K, et al. Diaphragm and lubricant gel for prevention of HIV acquisition in southern African women: A randomised controlled trial. Lancet 2007; 370:251-261.
22. Blanchard K, Bostrom A, Montgomery E, van der Straten A, Lince N, de Bruyn G, et al. Contraception use and effectiveness among women in a trial of the diaphragm for HIV prevention. Contraception 2011; 83:556-563.
23. Seaman SR, White IR. Review of inverse probability weighting for dealing with missing data. Stat Methods Med Res 2011 [Epub ahead of print].
24. Chen PL, Cole SR, Morrison CS. Hormonal contraception and HIV risk: evaluating marginal-structural-model assumptions. Epidemiology 2011; 22:877-878.
25. Comparison of female to male and male to female transmission of HIV in 563 stable couples. European Study Group on Heterosexual Transmission of HIV. BMJ 1992; 304:809-813.
26. Krishnan S, Dunbar MS, Minnis AM, Medlin CA, Gerdts CE, Padian NS. Poverty, gender inequities, and women's risk of human immunodeficiency virus/AIDS. Ann N Y Acad Sci 2008; 1136:101-110.
27. Ungchusak K, Rehle T, Thammapornpilap P, Spiegelman D, Brinkmann U, Siraprapasiri T. Determinants of HIV infection among female commercial sex workers in northeastern Thailand: results from a longitudinal study. J Acquir Immune Defic Syndr Hum Retrovirol 1996; 12:500-507.
28. Kumwenda JJ, Makanani B, Taulo F, Nkhoma C, Kafulafula G, Li Q, et al. Natural history and risk factors associated with early and established HIV type 1 infection among reproductive-age women in Malawi. Clin Infect Dis 2008; 46:1913-1920.
29. Polis C, Curtis K. Hormonal contraception and HIV acquisition in women: A systematic review of the epidemiological evidence. XIX International AIDS Conference. Washington, DC, 2012.
30. Lutalo T, Musoke R, Polis C, Serwadda D, Makumbi F, Nalugoda F, et al. Effects of Hormonal Contraceptive Use on HIV Acquisition in Women and Transmission to Men among HIV-discordant Couples, Rakai, Uganda. 19th Conference on Retroviruses and Opportunistic Infections. Seattle, 2012.
31. Singh S, Darroch JE, Ashford LS, Vlassoff M. Adding it up: the costs and benefits of investing in family planning and maternal and newborn health. New York: Guttmacher Institute and United Nations Population Fund; 2009.
32. Mugo NR, Heffron R, Donnell D, Wald A, Were EO, Rees H, et al. Increased risk of HIV-1 transmission in pregnancy: A prospective study among African HIV-1-serodiscordant couples. AIDS 2012; 25:1887-1895.
33. Cohen MS, Chen YQ, McCauley M, Gamble T, Hosseinipour MC, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med 2011; 365:493-505.
34. Butler AR, Smith JA, Polis CB, Gregson S, Stanton D, Hallett TB. Modelling the global competing risks of a potential interaction between injectable hormonal contraception and HIV risk. AIDS 2013; 27:105-113.
35. Pazol K, Kramer MR, Hogue CJ. Condoms for dual protection: patterns of use with highly effective contraceptive methods. Public Health Rep 2010; 125:208-217.
36. Sangi-Haghpeykar H, Posner SF, Poindexter AN 3rd. Consistency of condom use among low-income hormonal contraceptive users. Perspect Sex Reprod Health 2005; 37:184-191.
37. Robins JM, Hernan MA, Brumback B. Marginal structural models and causal inference in epidemiology. Epidemiology 2000; 11:550-560.